197 related articles for article (PubMed ID: 30510251)
41. A novel primary human immunodeficiency due to deficiency in the WASP-interacting protein WIP.
Lanzi G; Moratto D; Vairo D; Masneri S; Delmonte O; Paganini T; Parolini S; Tabellini G; Mazza C; Savoldi G; Montin D; Martino S; Tovo P; Pessach IM; Massaad MJ; Ramesh N; Porta F; Plebani A; Notarangelo LD; Geha RS; Giliani S
J Exp Med; 2012 Jan; 209(1):29-34. PubMed ID: 22231303
[TBL] [Abstract][Full Text] [Related]
42. WIP: more than a WASp-interacting protein.
Fried S; Matalon O; Noy E; Barda-Saad M
J Leukoc Biol; 2014 Nov; 96(5):713-27. PubMed ID: 25210148
[TBL] [Abstract][Full Text] [Related]
43. Toca-1 mediates Cdc42-dependent actin nucleation by activating the N-WASP-WIP complex.
Ho HY; Rohatgi R; Lebensohn AM; Le Ma ; Li J; Gygi SP; Kirschner MW
Cell; 2004 Jul; 118(2):203-16. PubMed ID: 15260990
[TBL] [Abstract][Full Text] [Related]
44. WASP and WIP regulate podosomes in migrating leukocytes.
Calle Y; Antón IM; Thrasher AJ; Jones GE
J Microsc; 2008 Sep; 231(3):494-505. PubMed ID: 18755005
[TBL] [Abstract][Full Text] [Related]
45. A complex of N-WASP and WIP integrates signalling cascades that lead to actin polymerization.
Moreau V; Frischknecht F; Reckmann I; Vincentelli R; Rabut G; Stewart D; Way M
Nat Cell Biol; 2000 Jul; 2(7):441-8. PubMed ID: 10878810
[TBL] [Abstract][Full Text] [Related]
46. Deleted in colorectal cancer binding netrin-1 mediates cell substrate adhesion and recruits Cdc42, Rac1, Pak1, and N-WASP into an intracellular signaling complex that promotes growth cone expansion.
Shekarabi M; Moore SW; Tritsch NX; Morris SJ; Bouchard JF; Kennedy TE
J Neurosci; 2005 Mar; 25(12):3132-41. PubMed ID: 15788770
[TBL] [Abstract][Full Text] [Related]
47. Cdc42 regulates Fc gamma receptor-mediated phagocytosis through the activation and phosphorylation of Wiskott-Aldrich syndrome protein (WASP) and neural-WASP.
Park H; Cox D
Mol Biol Cell; 2009 Nov; 20(21):4500-8. PubMed ID: 19741094
[TBL] [Abstract][Full Text] [Related]
48. Nucleophosmin-anaplastic lymphoma kinase: the ultimate oncogene and therapeutic target.
Werner MT; Zhao C; Zhang Q; Wasik MA
Blood; 2017 Feb; 129(7):823-831. PubMed ID: 27879258
[TBL] [Abstract][Full Text] [Related]
49. Cytokine receptor signaling is required for the survival of ALK- anaplastic large cell lymphoma, even in the presence of JAK1/STAT3 mutations.
Chen J; Zhang Y; Petrus MN; Xiao W; Nicolae A; Raffeld M; Pittaluga S; Bamford RN; Nakagawa M; Ouyang ST; Epstein AL; Kadin ME; Del Mistro A; Woessner R; Jaffe ES; Waldmann TA
Proc Natl Acad Sci U S A; 2017 Apr; 114(15):3975-3980. PubMed ID: 28356514
[TBL] [Abstract][Full Text] [Related]
50. STAT1 is phosphorylated and downregulated by the oncogenic tyrosine kinase NPM-ALK in ALK-positive anaplastic large-cell lymphoma.
Wu C; Molavi O; Zhang H; Gupta N; Alshareef A; Bone KM; Gopal K; Wu F; Lewis JT; Douglas DN; Kneteman NM; Lai R
Blood; 2015 Jul; 126(3):336-45. PubMed ID: 25921060
[TBL] [Abstract][Full Text] [Related]
51. NPM-ALK up-regulates iNOS expression through a STAT3/microRNA-26a-dependent mechanism.
Zhu H; Vishwamitra D; Curry CV; Manshouri R; Diao L; Khan A; Amin HM
J Pathol; 2013 May; 230(1):82-94. PubMed ID: 23338972
[TBL] [Abstract][Full Text] [Related]
52. WIP: WASP-interacting proteins at invadopodia and podosomes.
García E; Jones GE; Machesky LM; Antón IM
Eur J Cell Biol; 2012; 91(11-12):869-77. PubMed ID: 22823953
[TBL] [Abstract][Full Text] [Related]
53. Activation of compensatory pathways via Rac2 in the absence of the Cdc42 effector Wiskott-Aldrich syndrome protein in Dendritic cells.
Baptista MAP; Westerberg LS
Small GTPases; 2019 Mar; 10(2):81-88. PubMed ID: 28129089
[TBL] [Abstract][Full Text] [Related]
54. Cdc42-interacting protein 4 mediates binding of the Wiskott-Aldrich syndrome protein to microtubules.
Tian L; Nelson DL; Stewart DM
J Biol Chem; 2000 Mar; 275(11):7854-61. PubMed ID: 10713100
[TBL] [Abstract][Full Text] [Related]
55. Multilevel dysregulation of STAT3 activation in anaplastic lymphoma kinase-positive T/null-cell lymphoma.
Zhang Q; Raghunath PN; Xue L; Majewski M; Carpentieri DF; Odum N; Morris S; Skorski T; Wasik MA
J Immunol; 2002 Jan; 168(1):466-74. PubMed ID: 11751994
[TBL] [Abstract][Full Text] [Related]
56. The mechanism of CSF-1-induced Wiskott-Aldrich syndrome protein activation in vivo: a role for phosphatidylinositol 3-kinase and Cdc42.
Cammer M; Gevrey JC; Lorenz M; Dovas A; Condeelis J; Cox D
J Biol Chem; 2009 Aug; 284(35):23302-11. PubMed ID: 19561083
[TBL] [Abstract][Full Text] [Related]
57. β-catenin is constitutively active and increases STAT3 expression/activation in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.
Anand M; Lai R; Gelebart P
Haematologica; 2011 Feb; 96(2):253-61. PubMed ID: 20971814
[TBL] [Abstract][Full Text] [Related]
58. Waltzing with WASP.
Ramesh N; Antón IM; Martínez-Quiles N; Geha RS
Trends Cell Biol; 1999 Jan; 9(1):15-9. PubMed ID: 10087612
[TBL] [Abstract][Full Text] [Related]
59. WIP promotes in-vitro invasion ability, anchorage independent growth and EMT progression of A549 lung adenocarcinoma cells by regulating RhoA levels.
Salvi A; Thanabalu T
Biochem Biophys Res Commun; 2017 Jan; 482(4):1353-1359. PubMed ID: 27939884
[TBL] [Abstract][Full Text] [Related]
60. The nucleotide switch in Cdc42 modulates coupling between the GTPase-binding and allosteric equilibria of Wiskott-Aldrich syndrome protein.
Leung DW; Rosen MK
Proc Natl Acad Sci U S A; 2005 Apr; 102(16):5685-90. PubMed ID: 15821030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]